Evommune (EVMN) Prepaid Assets (2024 - 2026)
Evommune (EVMN) reported Prepaid Assets of $4.4 million for Q1 2026, up 2.64% quarter-over-quarter from $4.3 million in Q4 2025.
Evommune (EVMN) Prepaid Assets (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Prepaid Assets data on file, last reported at $4.4 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $4.4 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $4.4 million (changed N/A YoY), and the FY2025 annual result was $4.3 million, up 119.61% from the prior year.
- Prepaid Assets grew to $4.4 million in Q1 2026 per EVMN's latest filing, from $4.3 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $5.9 million in Q3 2025 and troughed at $1.9 million in Q4 2024.
- A 3-year average of $4.1 million and a median of $4.3 million in 2025 frame the typical range for Prepaid Assets.
- On a YoY basis, Prepaid Assets climbed as much as 119.61% in 2025 and fell as far as 119.61% in 2025.
- A 3-year view of Prepaid Assets shows it stood at $1.9 million in 2024, then jumped by 119.61% to $4.3 million in 2025, then advanced by 2.64% to $4.4 million in 2026.
- Business Quant data shows EVMN's Prepaid Assets at $4.4 million in Q1 2026, $4.3 million in Q4 2025, and $5.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Evommune | 695.29 Mn | 483.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.39 Mn |
| Dec 31, 2025 | 4.28 Mn |
| Sep 30, 2025 | 5.88 Mn |
| Dec 31, 2024 | 1.95 Mn |